GBA1 and Parkinson disease: This conclusion was further substantiated by the fact that after isolating the T/T carriers within the prodromal cohort, the remaining prodromal participants (T/C and C/C, GBA1 N370S) exhibited no significant difference in BMP levels compared to the PD cohort (Figure 4C).